Stocks in Focus

TXR Robotics Co., Ltd. Rises 29.9% Following U.S. Ban on Imports of Chinese-Made Humanoids

Kim Hyung-il
2026-07-29 10:44:33
[Edaily Reporter Kim Hyung-il ] #TXR Robotics Co., Ltd.’s stock price is surging in early trading. This is believed to reflect expectations that domestic robotics stocks will benefit from U.S. restrictions on imports of advanced robots from China.

(Photo: TXR Robotics Co., Ltd.)


According to MP Doctor on the 29th, TXR Robotics Co., Ltd. is trading at 14,460 won as of 10:35 a.m., up 29.92% from the previous trading day.

Overnight, the U.S. Federal Communications Commission (FCC) announced measures to restrict imports of new Chinese-made humanoid robots, quadruped robots, and power inverters, citing national security and the protection of critical infrastructure. The U.S. government explained that these devices could pose a threat to cybersecurity and supply chain stability. This move is interpreted as a policy aimed at strengthening restrictions on China’s advanced manufacturing sector while fostering the U.S. robotics industry.

Consequently, the market is highlighting the potential for domestic robotics and automation companies to benefit, leading to buying interest centered on robotics stocks.

TXR Robotics Co., Ltd. is a company that supplies logistics automation equipment—including wheel sorters, conveyors, piece-picking robots, and autonomous mobile robots (AMRs)—to logistics centers and manufacturing sites. The company possesses in-house technology ranging from design to installation and control software, and has recently been expanding its business scope to include special-purpose robots for firefighting, cleaning, and construction.

Economy

Corporation

IT·Science

Economy

[Market In] Turning to Bank Loans Instead of Corporate Bonds… Will Even A-Rated Companies Turn Their Backs on the Bond Market Next Year?

The slump in the non-investment-grade corporate bond market—which has been centered on BBB-rated bonds this year—is expected to spread to A-rated companies next year. As the burden of issuing corporat…
2026-11-14 16:05:05

Corporation

Rookie Baropharm and Embattled Moalife Plus Face Paradoxical Volatility as GC Genome Anchors the Market [K-Bio Pulse]

Amid broader market volatility on Thursday, South Korea’s biopharmaceutical sector lacked a clear directional trend, leaving traditional, profitable pharmaceutical and biotech firms to anchor investor…
2026-11-14 12:47:03

IT·Science

“The Era of 1.5 Million Robots”… The Korean Company JP Morgan Has Singled Out

A forecast indicates that U.S. production of humanoid robots will reach up to 400,000 units by 2030 and 1.5 million units by 2035. Analysts predict that as the humanoid robot industry moves beyond tec…
2026-11-14 08:36:21